Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Also known as: Blastic plasmacytoid dendritic cell neoplasia / Blastic Plasmacytoid Dendritic Cell Neoplasm / BPDCN / Blastic NK-cell lymphoma / Blastic plasmacytoid dendritic cell neoplasm (disorder) / Blastic plasmacytoid dendritic cell neoplasm (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|---|---|
DB14731 | Tagraxofusp | A CD123-directed cytotoxin used to treat blastic plasmacytoid dendritic cell neoplasm. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB14731 | Tagraxofusp | Interleukin-3 receptor subunit alpha | target |